Democritus University of Thrace (DUTH)
Οροτυπία και ευαισθησία στα αντιβιοτικά στελεχών πνευμονιόκοκκου στο ρινοφάρυγγα υγιών παιδιών προσχολικής ηλικίας στον Έβρο και ανταπόκριση του υπό κυκλοφορίας 13-δύναμου συζευγμένου εμβολίου
Abstract
dc:descriptionBackground: Streptococcus pneumoniae (SP) strains carried in the nasopharynx of healthy children reflect the circulating strains implicated in respiratory and invasive infections.Methods: We prospectively analysed the serotype distribution of SP nasopharyngeal isolates in healthy toddlers aged 21 to 78 months (median age 63 months) attending day care centres during the winters of 2010, 2011 and 2012, with the goal of predicting the future coverage of the recently licensed 13-valent pneumococcal conjugate vaccine (PCV13) in this population. Serotyping was performed by the Quellung reaction using the 12 pooled antisera Pneumotest panel and specific factor sera. We also studied the in vitro antimicrobial susceptibilities of the isolated pneumococci to several antibiotics by E-test, and for macrolide-resistant isolates of 2010 only, the resistance genes mef(A) and erm(B).Results: Among the 543 toddlers studied, 98.8% had received ≥1 dose of 7-valent pneumococcal conjugate vaccine (PCV7), while none was immunized with PCV10 or PCV13. Overall, 27.4% of the children tested were colonized with SP, while 22.8% and 52.3% of the isolates belonged to PCV7 and PCV13 serotypes, respectively. Overall, 25.5% of the isolates had intermediate resistance to penicillin (MIC 0.12-1) and 3.4% were resistant to penicillin (MIC 2μg/ml). All isolates were susceptible to amoxicillin, while 28.2% were resistant to macrolides, with the mef(A) gene-mediated M phenotype being the most common in 2010, the only year that macrolide resistance genes were studied (93.4% of macrolide-resistant isolates). Conclusion: Implementation of PCV13 will increase the coverage of children in our area for invasive pneumococcal serotypes by approximately 30%. Continued post-licensure serotyping and antimicrobial susceptibility surveillance is essential for designing rational immunization strategies and for providing guidance for appropriate treatment options for pneumococcal infections.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Themelidis, Dimitrios
- Θεμελίδης, Δημήτριος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33104